Shopping Cart
- Remove All
- Your shopping cart is currently empty
UTL-5g (3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl-) is a novel potential chemoprotective agent, TNF-α inhibitor that reduces cisplatin-induced side effects including nephrotoxicity, hepatotoxicity and hematotoxicity. It lowers elevated levels of AST, ALT, creatinine, BUN, and TNF-α, increases the reduced platelet count in mice, and acts as a novel chemo- and radioprotective agent.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 40 € | In Stock | |
5 mg | 101 € | In Stock | |
10 mg | 158 € | In Stock | |
25 mg | 321 € | In Stock | |
50 mg | 452 € | In Stock | |
100 mg | 644 € | In Stock | |
200 mg | 867 € | In Stock | |
1 mL x 10 mM (in DMSO) | 124 € | In Stock |
Description | UTL-5g (3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl-) is a novel potential chemoprotective agent, TNF-α inhibitor that reduces cisplatin-induced side effects including nephrotoxicity, hepatotoxicity and hematotoxicity. It lowers elevated levels of AST, ALT, creatinine, BUN, and TNF-α, increases the reduced platelet count in mice, and acts as a novel chemo- and radioprotective agent. |
In vivo | UTL-5g (GBL-5g) reduces elevated TGF-β and TNF-α levels resulting from lung irradiation[1]. |
Alias | GBL-5g, 3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl- |
Molecular Weight | 271.1 |
Formula | C11H8Cl2N2O2 |
Cas No. | 646530-37-2 |
Smiles | Cc1cc(no1)C(=O)Nc1ccc(Cl)cc1Cl |
Relative Density. | 1.469 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 27.5 mg/mL (101.44 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.